Use of lithium and cancer risk in patients with bipolar disorder

A very interesting article in the British Journal of Psychiatry (2016) 209,393-399 suggests that lithium inhibits glycogen synthase kinase-3 which is an enzyme involved in the pathogenesis of cancer. The article concluded that lithium is associated with reduced overall cancer risk in patients with bipolar disorder